Company Overview

We are leader in the field of IOeRT Linacs and FLASH Radiation Therapy systems

Italian passion for innovation in radiation therapy: we are a dynamic group of people moved by a strong passion for discovering, developing and producing new technologies to fight against cancer.

We are proud to be a designer and manufacturer rather than an integrator; this industrial choice guarantees a total control on all the key components of our IOeRT and FLASH systems.

Our Mission

Our mission is to revolutionize cancer treatment through the development and dissemination of Flash Therapy technology—a new frontier in radiotherapy that combines therapeutic effectiveness with reduced side effects.

 

We are committed to making this innovation accessible and integrable into multidisciplinary clinical practice, working closely with oncologists, radiation therapists, medical physicists, and researchers.

Our goal is to be a changemaker committed to supporting Flash Therapy as an additive treatment to the usual care, enhancing patients’ quality of life and promoting a personalized and sustainable approach to cancer care.

We are committed to making this innovation accessible and integrable into multidisciplinary clinical practice, working closely with oncologists, radiation therapists, medical physicists, and researchers.

Our goal is to be a changemaker committed to supporting Flash Therapy as an additive treatment to the usual care, enhancing patients’ quality of life and promoting a personalized and sustainable approach to cancer care.

Our Vision

Our company is committed to being a global leader in radiotherapy through continuous innovation and investment in research and development.

 

We aim to collaborate closely with doctors, patient associations, and government institutions from every country, regardless of GDP, to improve cancer diagnosis and treatment pathways.

 

Our vision is to make a significant contribution to reducing the impact of cancer on patients' lives and lowering mortality rates, promoting equitable and universal access to innovative treatments.

 

With an integrated and multidisciplinary approach, we are working towards a future where the fight against cancer is more effective, accessible, and sustainable for all.

Milestones History

In 2012 Sordina – the maker of LIAC – purchased NRT -the maker of NOVAC – resulting in the operation that is now S.I.T. – Sordina IORT Technologies S.p.A.

During the last few years, SIT has been developing innovative solutions for IOeRT and Flash RT achieving very important goals which can be translated in its flagship products:

LIAC HWL

A system capable of operating in any standard operating room solving completely any radiation protection issue;

IORT ECHO TPS

A Treatment Planning System which offers fast and precise real time intraoperative imaging allowing a smooth treatment planning and a perfect docking.

ELECTRONFLASH

The first dedicated FLASH radiation therapy pre-clinical research accelerator. This system represents for FLASH radiation therapy research community a unique technological solution capable not only of reaching impressive dose rates.

So...

The construction of electron accelerators for IOeRT and FLASH, requires a combination of high-level of expertise in different sectors, ranging from ultra-high vacuum technology to microwaves, radio-frequency emissions and high voltages. 

All people working at SIT are highly qualified and have considerable experience in linear accelerators design and manufacturing.

SIT can successfully carry out its activities thanks to its very well equipped and specialized manufacturing departments: copper machining laboratory, vacuum laboratory, radiofrequency laboratory, welding laboratory and assembling line. Furthermore, thanks to its two dedicated bunkers, all R&D or testing activities can be performed.

SIT has its registered office in Rome and its operational headquarters in Aprilia.

SIT has so far succeeded in building a large and solid network of agents, distributors and service engineers worldwide, who actively and continuously contribute to the promotion of high technologies in the field of IOeRT and FLASH therapy systems worldwide. 

SIT devices have been successfully installed in around 30 countries for a total number of 88 devices with more than 30.000 IOeRT treatments having been performed.

Milestones History

Our History

1997
NOVAC 7
Installation of the first NOVAC 7 produced by NRT at S. Filippo Neri Hospital (Rome).
2003
LIAC
Installation of the first LIAC produced by Sordina at IEO - European Institute of Oncology (Milan).
2012
Sordina - NRT
Sordina, by an M&A operation, purchases NRT.
2012
SIT
Constitution of SIT.
2013
SIT starts
SIT starts its business with the new brand.
2015
IOeRT
Patents obtained for the measurement of the IOeRT beam energy.
2017
LIAC HWL
CE certification for LIAC HWL.
2018
HWL Patent
Patent obtained for HWL (PCT/IT2019/050003).
2019
FLASH technique
Development of FLASH technique (patent pending).
2020
ElectronFlash
First installation of ElectronFlash (first half) and beginning of mass production (second half).
2025
ElectronFlash
Acquisition of SIT by San Carlo Invest Group, the clinical device for Flash RT will soon be on the market